A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated

NCT04863638 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

4400

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated
BIOLOGICAL: 3-doses schedule 2 of COVID-19 Vaccine (Vero Cell), Inactivated
BIOLOGICAL: 3-doses schedule 3 of COVID-19 Vaccine (Vero Cell), Inactivated
BIOLOGICAL: 2 doses of vaccine

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]